Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

Research and specialist diagnostic molecular services

We are a biomedical company with extensive experience in the molecular diagnostic field that allows us to improve the patient’s life quality by putting genetics at their service.

“In situ” hybridization (FISH)

Highly sensitive technique that allows us to detect chromosomal alterations (number of copies of a gene or a chromosomal rearrangements) in different neoplasms for diagnosis and/or targeted treatment, using probes labeled with a fluorochrome.

Molecular Biology

Molecular biology tools allow us to specifically detect and quantify the genetic material in a biological sample, having a great impact on both the diagnosis of cancer and hereditary and infectious diseases. The appearance of new faster and more precise techniques (arrays or NGS), allow us to perform global genomic analyzes in a short period of time.

News

MUTANT IDH1 INHIBITOR IVOSIDENIB COMBINED WITH AZACITIDINE FOR

The authors of this phase Ib trial evaluated the oral IDH1 inhibitor ivosidenib in

OLAPARIB FOR METASTATIC BREAST CANCER AND MUTATIONS IN

The authors of this phase II trial evaluated the PARP inhibitor olaparib in the

FDA APPROVES MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH

The U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in

FIVE-YEAR OUTCOMES WITH NIVOLUMAB IN PATIENTS WITH WILD-TYPE

The authors report the 5-year outcomes of this multicenter, double-blind, phase III study of

DARATUMUMAB FOR THE TREATMENT OF MULTIPLE MYELOMA IN

The authors of this review and meta-analysis of phase III trials evaluated the use

follow us

Do you need any of our services?

Write us